Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.63%1.58B | 8.75%389.77M | 0.57%427.96M | 1.81%435.16M | -0.25%331.95M | 10.14%1.54B | -0.99%358.4M | 2.73%425.56M | 16.15%427.42M | 29.13%332.79M |
Operating revenue | 2.16%729.39M | 4.14%-420.43M | -0.00%414.11M | 0.92%420.12M | -2.04%315.59M | 12.53%713.95M | -23.93%-438.6M | 8.17%414.12M | 16.91%416.27M | 162.22%322.17M |
Cost of revenue | -1.55%840.67M | -6.30%203.2M | -4.74%215.26M | 0.18%225.82M | 5.80%196.4M | 21.65%853.88M | 2.36%216.86M | 10.93%225.97M | 37.00%225.42M | 52.40%185.64M |
Gross profit | 7.81%744.17M | 31.82%186.57M | 6.57%212.71M | 3.63%209.34M | -7.89%135.55M | -1.40%690.28M | -5.72%141.53M | -5.21%199.59M | -0.70%202.01M | 8.26%147.16M |
Operating expense | 2.90%263.16M | -9.41%67.84M | 11.67%59.94M | 11.12%75.82M | 1.05%59.56M | 29.08%255.74M | 125.07%74.89M | -31.99%53.68M | 38.22%68.24M | 61.25%58.94M |
Selling and administrative expenses | 1.76%219.88M | -11.61%57.18M | 11.43%49.08M | 11.25%65M | -0.61%48.63M | 28.85%216.08M | 177.86%64.69M | -37.26%44.04M | 33.12%58.42M | 61.33%48.92M |
Depreciation amortization depletion | 9.14%43.28M | 4.59%10.66M | 12.75%10.86M | 10.34%10.83M | 9.10%10.94M | 30.35%39.66M | 2.02%10.19M | 10.39%9.63M | 79.08%9.81M | 60.86%10.02M |
-Depreciation and amortization | 9.14%43.28M | 4.59%10.66M | 12.75%10.86M | 10.34%10.83M | 9.10%10.94M | 30.35%39.66M | 2.02%10.19M | 10.39%9.63M | 79.08%9.81M | 60.86%10.02M |
Operating profit | 10.69%481.01M | 78.15%118.73M | 4.70%152.77M | -0.19%133.52M | -13.85%75.99M | -13.43%434.54M | -42.97%66.65M | 10.84%145.91M | -13.18%133.77M | -11.23%88.21M |
Net non-operating interest income expense | -40.11%-78.49M | -23.80%-18.98M | -37.53%-19.63M | -50.77%-21.43M | -51.22%-18.45M | -53.43%-56.02M | -58.35%-15.33M | -103.46%-14.27M | -47.69%-14.21M | -19.74%-12.2M |
Non-operating interest income | 11.36%8.65M | 8.35%2.09M | 27.10%2.41M | 17.46%2.42M | -8.07%1.73M | 6.53%7.76M | -5.12%1.93M | -19.21%1.9M | 26.29%2.06M | 47.11%1.88M |
Non-operating interest expense | 36.61%87.13M | 22.07%21.07M | 36.31%22.04M | 46.56%23.85M | 43.29%20.18M | 45.63%63.78M | 47.34%17.26M | 72.70%16.17M | 44.60%16.27M | 22.79%14.08M |
Other net income (expense) | 83.46%-6.88M | 112.52%1.96M | 138.49%4.01M | 164.13%4.49M | -103.53%-17.34M | -45.27%-41.57M | 57.76%-15.63M | -185.70%-10.41M | -202.20%-7.01M | -490.23%-8.52M |
Earnings from equity interest | 328.24%12.33M | 239.02%3.24M | -27.26%1.31M | 4,188.11%7.93M | -146.03%-155K | 66.22%2.88M | 111.04%956K | 67.53%1.8M | 562.50%185K | -125.82%-63K |
Special income (charges) | 68.12%-17.56M | 102.00%490K | 87.90%-1.32M | 90.46%-895K | -52.90%-15.84M | -136.18%-55.1M | 38.81%-24.49M | -181.25%-10.87M | -385.98%-9.38M | -35,831.03%-10.36M |
-Less:Restructuring and merger&acquisition | -69.10%17.23M | -101.95%-490K | -90.95%984K | -90.46%895K | 52.90%15.84M | 40.93%55.78M | --25.17M | --10.87M | --9.38M | --10.36M |
-Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --3.74M | ---- | ---- | ---- | ---- |
-Less:Other special charges | 107.50%331K | --0 | --331K | ---- | ---- | ---4.42M | ---- | ---- | ---- | ---- |
-Gain on sale of business | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -115.41%-1.64M | -122.46%-1.77M | 398.81%4.01M | -216.32%-2.54M | -170.02%-1.34M | 251.74%10.65M | 208.48%7.9M | 41.68%-1.34M | 139.34%2.19M | 211.19%1.91M |
Income before tax | 17.42%395.65M | 185.02%101.71M | 13.13%137.15M | 3.58%116.58M | -40.43%40.21M | -22.86%336.96M | -49.14%35.69M | -11.37%121.23M | -20.81%112.55M | -23.07%67.5M |
Income tax | 22.35%95.98M | 284.79%25.9M | 7.63%31.43M | 5.78%29.45M | -37.32%9.2M | -25.04%78.45M | -54.07%6.73M | -13.33%29.21M | -22.58%27.84M | -27.87%14.68M |
Net income | 15.92%299.67M | 161.82%75.8M | 14.88%105.72M | 2.86%87.14M | -41.29%31.01M | -22.17%258.51M | -47.84%28.95M | -10.73%92.02M | -20.21%84.71M | -21.62%52.82M |
Net income continuous Operations | 15.92%299.67M | 161.82%75.8M | 14.88%105.72M | 2.86%87.14M | -41.29%31.01M | -22.17%258.51M | -47.84%28.95M | -10.73%92.02M | -20.21%84.71M | -21.62%52.82M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 15.92%299.67M | 161.82%75.8M | 14.88%105.72M | 2.86%87.14M | -41.29%31.01M | -22.17%258.51M | -47.84%28.95M | -10.73%92.02M | -20.21%84.71M | -21.62%52.82M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 10.30%1.52M | 168.06%386K | 12.73%540K | 0.00%437K | -41.91%158K | -26.69%1.38M | -59.44%144K | -21.99%479K | -29.74%437K | -16.05%272K |
Net income attributable to common stockholders | 15.95%298.14M | 161.79%75.42M | 14.89%105.18M | 2.88%86.7M | -41.29%30.85M | -22.15%257.13M | -47.77%28.81M | -10.66%91.55M | -20.16%84.27M | -21.65%52.55M |
Basic earnings per share | 22.50%6.26 | 179.31%1.62 | 22.40%2.24 | 9.64%1.82 | -38.24%0.63 | -15.54%5.11 | -44.76%0.58 | -2.14%1.83 | -12.63%1.66 | -15.70%1.02 |
Diluted earnings per share | 22.29%6.2 | 174.14%1.59 | 22.65%2.22 | 9.09%1.8 | -39.22%0.62 | -15.36%5.07 | -44.23%0.58 | -2.16%1.81 | -12.70%1.65 | -15.00%1.02 |
Dividend per share | 0.00%1.15 | 0.00%0.2875 | 0.00%0.2875 | 0.00%0.2875 | 0.00%0.2875 | 21.05%1.15 | 21.05%0.2875 | 21.05%0.2875 | 21.05%0.2875 | 21.05%0.2875 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |